ITUS Corp  

(Public, NASDAQ:ITUS)   Watch this stock  
Find more results for OTCBB:COPY
+0.22 (10.73%)
Sep 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.01 - 2.50
52 week 0.60 - 6.82
Open 2.13
Vol / Avg. 5.88M/2.18M
Mkt cap 34.32M
P/E     -
Div/yield     -
EPS -0.64
Shares 15.12M
Beta -1.47
Inst. own 1%

Key stats and ratios

Q3 (Jul '17) 2016
Net profit margin -495.01% -1672.14%
Operating margin -477.50% -1503.00%
EBITD margin - -1348.05%
Return on average assets -91.90% -67.05%
Return on average equity -158.58% -166.85%
Employees 7 -
CDP Score - -


3150 Almaden Expy Ste 250
SAN JOSE, CA 95118-1250
United States - Map
+1-310-4845200 (Phone)
+1-631-5495974 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


ITUS Corporation is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. Instead of seeking to alter or boost the body's immune system and its ability to destroy cancer cells, the Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients, and in distinguishing the blood of healthy patients from the blood of cancer patients.

Officers and directors

Amit Kumar Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 53
Bio & Compensation  - Reuters
Michael J. Catelani Chief Financial Officer, Chief Operating Officer
Age: 50
Bio & Compensation  - Reuters
Lewis H. Titterton Jr. Director
Age: 73
Bio & Compensation  - Reuters
Dale Fox Independent Director
Bio & Compensation  - Reuters
Bruce F. Johnson Independent Director
Age: 73
Bio & Compensation  - Reuters